Filter
10257
Filtered Results: 10257
Text search:
control
of
disease
Featured
Recommendations
978
New Publications
2442
Language
Document type
No document type
5291
Studies & Reports
1666
Guidelines
1574
Manuals
487
Fact sheets
365
Strategic & Response Plan
356
Training Material
168
Situation Updates
104
Infographics
76
Resource Platforms
59
Online Courses
54
Brochures
37
Videos
14
Dashboards/Maps
4
App
2
Countries / Regions
Global
462
India
441
Sierra Leone
266
Kenya
254
Liberia
228
Western and Central Europe
215
Africa
211
South Africa
208
Nigeria
205
Ethiopia
197
Latin America and the Carribbean
181
Uganda
161
Congo, Democratic Republic of
146
Nepal
141
Rwanda
131
Tanzania
119
Guinea
115
Brazil
115
Malawi
114
Mozambique
113
Ghana
109
Bangladesh
109
Zambia
106
West and Central Africa
104
Syria
99
Middle East and North Africa
96
Myanmar / Burma
93
Senegal
91
Russia
89
Ukraine
86
East and Southern Africa
84
South Sudan
78
Eastern Europe
78
Philippines
77
Haiti
73
Burkina Faso
67
Namibia
66
South–East Asia Region
62
Yemen
60
Zimbabwe
56
Germany
56
Colombia
55
Asia
55
Mali
51
Angola
50
Indonesia
49
Cambodia
48
Côte d’Ivoire / Ivory Coast
47
Cameroon
46
Lesotho
46
Guinea-Bissau
43
Eastern Europe and Central Asia
39
Venezuela
39
Botswana
33
Chad
32
Paraguay
27
Niger
26
Pakistan
26
Sudan
25
Eswatini/ Swaziland
25
Western Pacific Region
25
Madagascar
24
USA
23
Argentina
23
Chile
23
Somalia
21
Afghanistan
21
Benin
20
Peru
20
Ecuador
20
Vietnam
19
Spain
17
China
16
Bolivia
16
Thailand
15
Central African Republic
15
North America
14
Iraq
13
Albania
12
Lebanon
11
Tajikistan
11
Jordan
10
Saudi Arabia
9
Togo
9
Southern Africa
9
Laos
9
Moldova
9
Georgia
9
Portugal
9
Egypt
8
Papua New Guinea
8
Sri Lanka
8
Italy
8
Turkey
7
Burundi
7
Libya
6
Mexico
6
Palestine
6
Timor Leste/ East Timor
6
Iran
6
Gambia
5
North Macedonia
5
Armenia
5
Kazakhstan
5
United Kingdom
5
Malaysia
4
Honduras
4
El Salvador
4
Bhutan
4
Poland
4
Romania
4
Turkmenistan
4
Japan
4
France
4
Tunisia
4
Singapore
3
Hungary
3
North Korea
3
Djibouti
3
Congo-Brazzaville
3
Kyrgyzstan
3
Gabon
3
Jamaica
3
Mauritius
3
Belarus
3
Morocco
2
Mauritania
2
Ireland
2
Dominican Republic
2
Greece
2
Other region
2
Fiji
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Uruguay
2
Belgium
2
South Korea
2
Bosnia and Herzegovina
2
Vanuatu
1
Austria
1
Switzerland
1
Serbia
1
Guatemala
1
Cape Verde
1
Solomon Islands
1
Mongolia
1
Lithuania
1
Australia
1
Denmark
1
Maldives
1
Algeria
1
Morocco
1
Azerbaijan
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3694
Clinical Guidelines
874
Public Health
659
Key Resources
410
Women & Child Health
357
Capacity Building
165
Pharmacy & Technologies
134
Annual Report MEDBOX
2
Toolboxes
COVID-19
1439
HIV
657
TB
657
Mental Health
621
Ebola
551
Rapid Response
412
NTDs
365
AMR
352
Planetary Health
325
NCDs
323
Caregiver
241
Conflict
170
Zika
158
Disability
157
Pharmacy
151
Refugee
141
Global Health Education
137
Cholera
124
Natural Hazards
106
Health Financing Toolbox
80
Specific Hazards
65
Polio
63
Social Ethics
23
Typhoon
5
Health Financing
3
South Sudan
2
Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination ... the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coordinated by WHO-PAHO, much has been accomplished in these domains in terms of reducing transmission. Attention now turns to consolidating the successes in interrupting transmission, and improved treatment for those already infected and those who may become affected in the future. This article, based on technical discussions at the "Epidemiological and Sociological Determinants of Chagas Disease, Basic Information to Establish a Surveillance and Control Policy " meeting in Rio de Janeiro, is designed to open the debate on appropriate strategies for continuation of the successful initiatives against Chagas disease.
The Coronavirus disease (COVID-19) pandemic has revealed the fragility of pre-crisis African health systems, in which too little was invested over the past decades. Yet, development assistance for h...
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control ... arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that expertise, FIP joined efforts with the PFA and is now publishing its first-ever handbook to support pharmacists in the
area of vector-borne diseases. As the integration of the regional forums in FIP advances, such collaborative projects are tangible results of an increasingly regionally informed and regionally targeted work by FIP.
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust ...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use ... the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus.
2 Rabies virus is the most important lyssavirus globally. In the
United States, multiple rabies virus variants are maintained in wild mammalian reservoir populations such as raccoons, skunks, foxes, and bats. Although the United States has been declared free from transmission of canine rabies virus variants, there is always a risk of reintroduction of these variants.The rabies virus is usually transmitted from animal to animal through bites. The incubation period is
highly variable. In domestic animals, it is generally 3 to 12 weeks, but can range from several days to months, exceeding 6 months.8 Rabies is communicable during the period of salivary shedding of rabies virus. Experimental and historic evidence documents that dogs, cats, and ferrets shed the virus for a few days prior to the onset of clinical signs and during illness. Clinical signs of rabies are variable and include inappetance, dysphagia, cranial nerve deficits, abnormal behavior, ataxia, paralysis, altered vocalization, and seizures. Progression to death is rapid. There are currently no known effective rabies antiviral drugs.
Introduction Community health workers (CHWs) are increasingly being tasked to prevent and manage cardiovascular disease (CVD) and its risk factors in underserved populations in low-income and middle-income countries (LMICs); however, little is known...
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing...
Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation ... cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packages that are cost-effective and suited to low-resource settings. Main messages from the volume include:
-Quality matters in all aspects of cancer treatment and palliation.
-Cancer registries that track incidence, mortality, and survival paired with systems to capture causes of death are important to understanding the national cancer burden and the effect of interventions over time.
-Effective interventions exist at a range of prices. Adopting ‘resource appropriate’ measures which allow the most effective treatment for the greatest number of people will be advantageous to countries.
-Prioritizing resources toward early stage and curable cancers is likely to have the greatest health impact in low income settings.
-Research prioritization is no longer just a global responsibility.
Coronavirus disease 2019 has a mild disease course in children and adolescents. Chronic respiratory conditions, including asthma, have been suggested as risk factors; however, asthma in children is ...
As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discu...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
... millions more. These diseases erode the health
and well-being of the patients and have a negative
impact on families and societies. Women and
children are particularly vulnerable, especially those
in low and middle income countries, where they are
exposed on a daily basis to indoor air pollution from
solid fuels for cooking and heating. In high income
countries, tobacco is the most important risk factor
for chronic respiratory diseases, and in some of
these countries, tobacco use among women and
young people is still increasing.
Comprehensive Primary Health Care has an important role in the primary and secondary prevention of several disease conditions, including non-communicable ...s which today contribute to over 60% of the mortality in India. The provision of Comprehensive primary health care reduces morbidity, disability and mortality at much lower costs and significantly reduces the need for secondary and tertiary care. Estimates suggest that almost 52% of all conditions can be managed at the
primary care level.
In order to ensure comprehensive primary health care, close to where people live, Sub- Centres should be strengthened as Health and Wellness Centres (H&WC), staffed by appropriately trained primary health care team. The Medical officer of the Primary Health Centre would oversee the functioning of the SC/HWC that falls in that area.
Services include those that (i) can be delivered at the level of the household and outreach sites in the community by suitably trained frontline workers, (ii) those that are delivered by a team headed by a mid-level health provider, at the level of the Sub-Centre/Health and Wellness Centre and (iii) the referral support and continuity of care within the district health system in rural and urban areas. The package of services is in Box. States would need to either phase in these services or add on additional services based on state specific and local context.
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the ..., and reducing spillover of the virus from animals to humans.
Mpox is a viral illness caused by the monkeypox virus (MPXV). It can cause a painful rash, enlarged lymph nodes and fever. Most people fully recover, but some get very sick. The virus transmits from person to person through close, including sexual, contact. It also has animal reservoirs in east, central and west Africa, where spillovers from animals to humans can occasionally occur, sparking further outbreaks.
There are two different clades of the virus: clade I and clade II. Clade I outbreaks are deadlier than clade II outbreaks.
A major emergence of mpox linked to clade II began in 2017, and since 2022, has spread to all regions of the world. Between July 2022 and May 2023, the outbreak was declared a Public Health Emergency of International Concern. While that outbreak has largely subsided, cases and deaths continue to be reported today, illustrating that low-level transmission continues around the world.
Currently, there is also a major outbreak of clade I virus in the Democratic Republic of the Congo (DRC), where cases have been on the rise for decades. Since the beginning of the year, over 6500 cases and 345 deaths have been reported in the DRC. Almost half of these are among children under the age of 15 years.
The Strategic framework for enhancing prevention and control of mpox (2024–2027) provides a roadmap for health authorities, communities, and stakeholders worldwide to control mpox outbreaks in every context, advance mpox research and access to countermeasures, and to minimize zoonotic transmission.
Annex. This document is an update of a guidance published on 12 July 2021, after the review of new scientific evidence on transmission of SARS-CoV-...
WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
recommended
Human strongyloidiasis is a chronic parasitic disease caused by infection with Strongyloides stercoralis, a soil-transmitted helminth that is estimated to infect 300–600 million people worldwide. This neglected tropical ... (NTD) is endemic globally, predominately in the South-East Asia, African and Western Pacific regions, and in South and Central America. Strongyloidiasis has a wide range of clinical presentations, including subclinical disease, symptomatic disease (often with diarrhoea, abdominal pain and urticaria) and a rare but deadly complication of hyperinfection with disseminated disease. The feared complication of disseminated strongyloidiasis can occur in the setting of immunocompromising conditions (e.g. human T-cell lymphotropic virus type 1 infection and malignancies) or immunosuppressive medications (e.g. steroids) and has an estimated case-fatality rate exceeding 60%. The standard treatment for chronic S. stercoralis infection is oral medication with ivermectin.
Interim Guidance. This document provides guidance for: screening and triage of pregnant women in the context of an Ebola outbreak; infection prevention and ... (IPC) precautions for pregnant women at risk of EVD transmission during childbirth and complication management; management of pregnant EVD cases, contacts and survivors; lactation and Ebola virus disease.
This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to...
For over 23 years, CDC has collaborated in Malawi with local and international partners to strengthen health systems. The office works to prevent, detect and respond to diseases. Efforts include building healthcare workforce capacity, strengthening ...
